Sort
48,018 grants matching “immunotherapy”
Metastatic Clonal Heterogeneity and its Impact on Melanoma Therapeutic Resistance
$462,960Willy Hugo · University Of California Los Angeles · R01 · FY2021 · CA
Metastatic Clonal Heterogeneity and its Impact on Melanoma Therapeutic Resistance
$462,960Willy Hugo · University Of California Los Angeles · R01 · FY2022 · CA
Vanderbilt Network Lead Academic Participating Site for the NCTN
$462,912Kristen Keon Ciombor · Vanderbilt University Medical Center · UG1 · FY2024 · CA
Liquid biopsy-based toolkits for neoantigen and cognate TCR discovery for cancer immunotherapy
$462,881Wei Wei · Institute For Systems Biology · R33 · FY2021 · CA
Understanding the influence of bone-metastatic prostate cancer and mesenchymal stromal cells on γδ T cells, in the bone microenvironment.
$462,850Daniel Abate-Daga · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
Core D: Pathology and BioImaging
$462,848Carl D Morrison · Roswell Park Cancer Institute Corp · P01 · FY2021 · CA
Vascular image-guided optimization of response (VIGOR) to therapy in kidney cancer
$462,812Li Liu · Ut Southwestern Medical Center · R01 · FY2024 · CA
Decoding tobacco-related oral cancer ecosystem by integrative approach
$462,811Aik Choon Tan · University Of Utah · R01 · FY2022 · DE
An Environmental Chemical Receptor, the AhR, as a Mediator of Multiple Immune Checkpoints in Oral Cancer
$462,785David H Sherr · Boston University Medical Campus · R01 · FY2022 · ES
Chitinase-3-like-1 mediated immunosuppression in Glioblastoma
$462,773Baoli Hu · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer
$462,770Lily Yang · Emory University · R01 · FY2023 · CA
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer
$462,770Lily Yang · Emory University · R01 · FY2022 · CA
Targeting ferroptosis in aggressive subtypes of lung cancer
$462,704Triparna Sen · Ohio State University · R01 · FY2025 · CA
Canine MHC-I genotyping and tumor specific neoantigen determination
$462,701Shaying Zhao · University Of Georgia · R01 · FY2023 · CA
Leveraging the metastatic tumor stroma to limit breast cancer progression
$462,667Sheila A Stewart · Washington University · R01 · FY2025 · CA
Modeling immunity with a hybrid lymph node tissue-chip
$462,626Rebecca R Pompano · University Of Virginia · R01 · FY2020 · AI
Mechanisms and Vulnerabilities of SWI/SNF chromatin remodeling complex mutant lung cancer
$462,600Yonathan Lissanu · University Of Tx Md Anderson Can Ctr · R37 · FY2023 · CA
EXPRESSION OF TUBERCULOSIS IN THE LUNG
$462,590Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2004 · HL
Role of heat shock transcription factors (HSFs) in hematological malignancies
$462,585Nahid F Mivechi · Augusta University · R01 · FY2025 · CA
Role of heat shock transcription factors (HSFs) in hematological malignancies
$462,585Nahid F Mivechi · Augusta University · R01 · FY2023 · CA
Defining epigenetic signaling to reshape pancreatic tumor microenvironment
$462,567Jiaqi Shi · University Of Michigan At Ann Arbor · R37 · FY2022 · CA
Clinical treatment of advanced Merkel cell carcinoma
$462,527Isaac Brownell · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2022 · AR
Function of IL35+ B cells in pancreatic cancer
$462,460Yuliya Pylayeva-Gupta · Univ Of North Carolina Chapel Hill · R37 · FY2019 · CA
Developmental Funds
$462,458Peter A Jones · University Of Southern California · P30 · FY2015 · CA
Effects of autoantibodies on synaptic transmission in the retina
$462,428Catherine W Morgans · Oregon Health & Science University · R01 · FY2015 · EY